Kinesin family member 15 can promote the proliferation of glioblastoma

• 出版年: Mathematical Biosciences and Engineering
• 主要な著者: Leibo Wang, Xuebin Zhang, Jun Liu, Qingjun Liu
• フォーマット: 論文
• 言語: 英語
• 出版事項: AIMS Press 2022-06-01
• 主題: glioblastoma; kinesin family member 15 (kif15); proliferation; clinical characteristics; therapeutic target
• オンライン･アクセス: https://www.aimspress.com/article/doi/10.3934/mbe.2022384?viewType=HTML

Glioblastoma is one of the most dangerous tumors for patients in clinical practice at present, and since glioblastoma originates from the brain, it will have a serious impact on patients. Therefore, more effective clinical therapeutic targets are still needed at this stage. Kinesin family member 15 (KIF15) promotes proliferation in several cancers, but its effect on glioblastoma is unclear. In this study, differentially expressed gene analysis and network analysis were performed to identify critical genes affecting glioma progression. The samples were divided into a KIF15 high-expression group and KIF15 low-expression group, and the association between FIK15 expression level and clinical characteristics was summarized and analyzed by performing medical data analysis; the effect of KIF15 on glioblastoma cell proliferation was detected by employing colony formation and MTT assays. The effect of KIF15 on tumor growth in mice was determined. It was found that KIF15 was a potential gene affecting the progression of glioblastoma. In addition, KIF15 was highly expressed in glioblastoma tumor tissues, and KIF15 was correlated with tumor size, clinical stage and other clinical characteristics. After the KIF15 gene was knocked out, the proliferation ability of glioblastoma was significantly inhibited. KIF15 also contributed to the growth of glioblastoma tumors in mice. Therefore, we found KIF15 to be a promising clinical therapeutic target.